Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Millan

Showing results (91-100 of 496) with videos related to

Pageof 50
Sort By:
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|March 1, 1978
[Results of 3 years of screening of abnormal hemoglobins in the blood donors of Guadeloupe (French Antilles)]H Fabritius, J Millan, Y Le Corroller
Neuropharmacology|April 2, 2003
Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907A Dekeyne, L Iob, M J Millan
Neuroscience Letters|November 7, 1994
Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychoticsH Canton, L Verrièle, M J Millan
Psychopharmacology|October 9, 2007
Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortexFlorence Loiseau, Anne Dekeyne, Mark J Millan
The International Journal of Neuropsychopharmacology|July 8, 2011
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxineFlorence Serres, Mark J Millan, Trevor Sharp
European Journal of Pharmacology|October 13, 1994
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidoneR Schreiber, M Brocco, M J Millan
Psychopharmacology|March 29, 2001
Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in ratsA Dekeyne, L Iob, M J Millan
European Journal of Pharmacology|February 6, 2004
Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapineDidier Cussac, Valérie Pasteau, Mark J Millan
Pain|September 1, 1982
Evidence for an interrelationship between ventral noradrenergic bundle and CNS endorphins in the control of nociception in the ratM J Millan, M H Millan, A Herz
Acta Leprologica|January 1, 1986
[A survey for school screening in Senegal: considerations on the usefulness of this screening method and on the importance of endemicity among the youthful population of leprosy villages]J Millan, A Sanokho, M Camara, et al.
Pageof 50

Showing results (91-100 of 496) with videos related to

Sort By:
Pageof 50
Bulletin De La Societe De Pathologie Exotique Et De Ses Filiales|March 1, 1978
[Results of 3 years of screening of abnormal hemoglobins in the blood donors of Guadeloupe (French Antilles)]H Fabritius, J Millan, Y Le Corroller
Neuropharmacology|April 2, 2003
Generalization of clozapine as compared to other antipsychotic agents to a discriminative stimulus elicited by the serotonin (5-HT)2A antagonist, MDL100,907A Dekeyne, L Iob, M J Millan
Neuroscience Letters|November 7, 1994
Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychoticsH Canton, L Verrièle, M J Millan
Psychopharmacology|October 9, 2007
Pro-cognitive effects of 5-HT6 receptor antagonists in the social recognition procedure in rats: implication of the frontal cortexFlorence Loiseau, Anne Dekeyne, Mark J Millan
The International Journal of Neuropsychopharmacology|July 8, 2011
Molecular adaptation to chronic antidepressant treatment: evidence for a more rapid response to the novel α₂-adrenoceptor antagonist/5-HT-noradrenaline reuptake inhibitor (SNRI), S35966, compared to the SNRI, venlafaxineFlorence Serres, Mark J Millan, Trevor Sharp
European Journal of Pharmacology|October 13, 1994
Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidoneR Schreiber, M Brocco, M J Millan
Psychopharmacology|March 29, 2001
Following long-term training with citalopram, both mirtazapine and mianserin block its discriminative stimulus properties in ratsA Dekeyne, L Iob, M J Millan
European Journal of Pharmacology|February 6, 2004
Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapineDidier Cussac, Valérie Pasteau, Mark J Millan
Pain|September 1, 1982
Evidence for an interrelationship between ventral noradrenergic bundle and CNS endorphins in the control of nociception in the ratM J Millan, M H Millan, A Herz
Acta Leprologica|January 1, 1986
[A survey for school screening in Senegal: considerations on the usefulness of this screening method and on the importance of endemicity among the youthful population of leprosy villages]J Millan, A Sanokho, M Camara, et al.
Pageof 50